Schroeder T, Stelljes M, Christopeit M, Esseling E, Scheid C, Mikesch J-H, Rautenberg C, Jäger P, Cadeddu R-P, Drusenheimer N, Holtick U, Klein S, Trenschel R, Haas R, Germing U, Kröger N, Kobbe G. Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial. haematol [Internet]. 2023Jun.1 [cited 2023Nov.30];108(11):3001-10. Available from: https://haematologica.org/article/view/haematol.2022.282570